All Stories

  1. Composition of Troponin Release After Elective On‐Pump and Off‐Pump Cardiac Surgery
  2. Prophylactic Surgical Left Atrial Appendage Closure in Bioprosthetic Aortic Valve Replacement: Short‐Term Outcomes of Randomized Controlled LAA–CLOSURE Trial
  3. Sleep apnea is associated with new-onset atrial fibrillation in patients undergoing peritoneal dialysis
  4. Real-world performance of postpericardiotomy syndrome diagnostic criteria—An analysis of the prospective Cardiovascular Research Consortium—A Prospective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patient...
  5. Prolonged Systemic Inflammatory Response Syndrome Predicts Atrial Fibrillation after Cardiac Surgery
  6. Randomized trial of smartphone application and bed sensor for atrial fibrillation detection in high-risk patients
  7. Assessing the impact of signal quality on heart rate detection from long-term clinical wrist PPG under varying cardiac rhythms
  8. Major bleeding complications and antithrombotic treatment after isolated surgical bioprosthetic aortic valve replacement
  9. Adaptive Autocorrelation Based Heart Rate Estimation from Single-Axis Seismocardiogram: A Comprehensive Benchmark Across Six Diverse Datasets
  10. Prevalence and progression of P-wave abnormalities in patients with atrial fibrillation
  11. Heart Rate Estimation Through Autocorrelation from Single Axis Accelerometer of Smartphone
  12. Lightweight ResNet-Based Deep Learning for Photoplethysmography Signal Quality Assessment
  13. Validation of an MEMS-Based Pressure Sensor System for Atrial Fibrillation Detection From Wrist and Finger
  14. Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use
  15. Quality of anticoagulation and outcomes after mechanical aortic valve replacement in patients with atrial fibrillation: a nationwide cohort study
  16. Bed sensor ballistocardiogram for non-invasive detection of atrial fibrillation: a comprehensive clinical study
  17. QClus: a droplet filtering algorithm for enhanced snRNA-seq data quality in challenging samples
  18. Ferric carboxymaltose in reducing blood transfusions and infections after cardiac surgery
  19. Novel electrocardiographic classification for stroke prediction in atrial fibrillation patients undergoing cardioversion
  20. Vascular disease and ischemic stroke in patients with atrial fibrillation: Temporal trends and age-related differences
  21. In Reply to the Letter to the Editor Regarding “Positive Correlation Between Thoracic Aortic Diameter and Intracranial Aneurysm Size—An Observational Cohort Study”
  22. Major bleeding complications and antithrombotic treatment after isolated surgical bioprosthetic aortic valve replacement
  23. Association between aortic calcification and cytokine levels in patients with peripheral artery disease
  24. Distinct circulating cytokine levels in patients with angiography-proven coronary artery disease compared to disease-free controls
  25. Performance of D-dimer, cardiac troponin T, C-reactive protein, and NT-proBNP in prediction of long-term mortality in patients with suspected pulmonary embolism
  26. Differential circulating cytokine profiles in acute coronary syndrome versus stable coronary artery disease
  27. Genetics, transcriptomics, metagenomics, and metabolomics in the pathogenesis and prediction of atrial fibrillation
  28. Transcriptomic and spatial dissection of human ex vivo right atrial tissue reveals proinflammatory microvascular changes in ischemic heart disease
  29. Positive Correlation Between Thoracic Aortic Diameter and Intracranial Aneurysm Size–An Observational Cohort Study
  30. Classification of the Urgency of the Procedure and Outcome of Acute Type A Aortic Dissection
  31. Prolonged Systemic Inflammatory Response Syndrome After Cardiac Surgery
  32. Fibrillatory wave amplitude and thromboembolic risk in non-anticoagulated patients with atrial fibrillation
  33. The Role of MAPRE2 and Microtubules in Maintaining Normal Ventricular Conduction
  34. Temporal Relation Between Myocardial Infarction and New-Onset Atrial Fibrillation: Results from a Nationwide Registry Study
  35. Ischemic Stroke Temporally Associated With New-Onset Atrial Fibrillation: A Population-Based Registry-Linkage Study
  36. Risk of fluid accumulation after cardiac surgery
  37. Antithrombotic Medication and Major Complications After Mechanical Aortic Valve Replacement
  38. Mechanocardiography-Based Measurement System Indicating Changes in Heart Failure Patients during Hospital Admission and Discharge
  39. Disadvantages of high fluid infusion rate in cardiac surgery
  40. Late incidence and recurrence of new-onset atrial fibrillation after isolated surgical aortic valve replacement
  41. Mechanocardiography in the Detection of Acute ST Elevation Myocardial Infarction: The MECHANO-STEMI Study
  42. End-to-end sensor fusion and classification of atrial fibrillation using deep neural networks and smartphone mechanocardiography
  43. Frequency of cardioversions as an additional risk factor for stroke in atrial fibrillation – the FinCV-4 study
  44. Polygenic Risk Scores for Predicting Adverse Outcomes After Coronary Revascularization
  45. Red blood cell transfusion induces abnormal HIF-1α response to cytokine storm after adult cardiac surgery
  46. Intracranial aneurysm is predicted by abdominal aortic calcification index: A retrospective case-control study
  47. A randomized prospective multicenter trial for stroke prevention by prophylactic surgical closure of the left atrial appendage in patients undergoing bioprosthetic aortic valve surgery––LAA-CLOSURE trial protocol
  48. Anticoagulation Therapy After Biologic Aortic Valve Replacement
  49. Minor troponin T elevation and mortality in patients with atrial fibrillation presenting to the emergency department
  50. Adherence to risk-assessment protocols to guide computed tomography pulmonary angiography in patients with suspected pulmonary embolism
  51. Inadequate oral anticoagulation with warfarin in women with cerebrovascular event and history of atrial fibrillation: the FibStroke study
  52. Advanced interatrial block predicts ineffective cardioversion of atrial fibrillation: a FinCV2 cohort study
  53. Elevated Troponin T and Enlarged Left Atrium Are Associated with the Incidence of Atrial Fibrillation in Patients with CKD Stage 4–5
  54. Adverse events and survival with postpericardiotomy syndrome after surgical aortic valve replacement
  55. Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis
  56. Interatrial block, P terminal force or fragmented QRS do not predict new-onset atrial fibrillation in patients with severe chronic kidney disease
  57. Association of Heart Rate With Troponin Levels Among Patients With Symptomatic Atrial Fibrillation
  58. Indications and predictors for pacemaker implantation after isolated aortic valve replacement with bioprostheses: the CAREAVR study
  59. Classification of Atrial Fibrillation and Acute Decompensated Heart Failure Using Smartphone Mechanocardiography: A Multilabel Learning Approach
  60. Postpericardiotomy syndrome after cardiac surgery
  61. Full feature selection for estimating KAP radiation dose in coronary angiographies and percutaneous coronary interventions
  62. Preoperative paroxysmal atrial fibrillation predicts high cardiovascular mortality in patients undergoing surgical aortic valve replacement with a bioprosthesis: CAREAVR study
  63. Metastable Atrial State Underlies the Primary Genetic Substrate for MYL4 Mutation-Associated Atrial Fibrillation
  64. CONTEMPORARY RADIATION DOSES IN INTERVENTIONAL CARDIOLOGY: A NATIONWIDE STUDY OF PATIENT SKIN DOSES IN FINLAND
  65. Etiology of Minor Troponin Elevations in Patients with Atrial Fibrillation at Emergency Department–Tropo-AF Study
  66. Population trends in aortic valve surgery in Finland between 2001 and 2016
  67. Evolving Field of Long-term Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation
  68. Assessment of myocardial viability with [15O]water PET: A validation study in experimental myocardial infarction
  69. Distribution of ischemic strokes in patients with atrial fibrillation
  70. Clinical assessment of a non-invasive wearable MEMS pressure sensor array for monitoring of arterial pulse waveform, heart rate and detection of atrial fibrillation
  71. CONTEMPORARY RADIATION DOSES IN INTERVENTIONAL CARDIOLOGY: A NATIONWIDE STUDY OF PATIENT DOSES IN FINLAND
  72. Reliability of Self-Applied Smartphone Mechanocardiography for Atrial Fibrillation Detection
  73. Machine Learning Based Classification of Myocardial Infarction Conditions Using Smartphone-Derived Seismo- and Gyrocardiography
  74. Preoperative myocardial troponin T elevation is associated with the fracture type in patients with proximal femoral fracture
  75. Occurrence of Postpericardiotomy Syndrome: Association With Operation Type and Postoperative Mortality After Open‐Heart Operations
  76. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
  77. Cardioversion for atrial fibrillation – how to prevent thromboembolic complications?
  78. Meta-analysis of the Sources of Bleeding after Adult Cardiac Surgery
  79. P5338The occurrence of postpericardiotomy syndrome: association with operation type and post-operative mortality after open-heart operations
  80. P1655Preoperative predictors for systemic inflammatory response in open-heart surgery
  81. Traumatic and spontaneous intracranial hemorrhage in atrial fibrillation patients on warfarin
  82. Optimal timing for cardioversion in patients with atrial fibrillation
  83. Performance of CHA2DS2-VASc score for stroke prediction after surgical aortic valve replacement
  84. Multiclass Classifier based Cardiovascular Condition Detection Using Smartphone Mechanocardiography
  85. How do anticoagulated atrial fibrillation patients who suffer ischemic stroke or spontaneous intracerebral hemorrhage differ?
  86. Usefulness of the CHA 2 DS 2 -VASc and HAS-BLED Scores in Predicting the Risk of Stroke Versus Intracranial Bleeding in Patients With Atrial Fibrillation (from the FibStroke Study)
  87. Impact of preoperative thrombocytopenia on the outcome after coronary artery bypass grafting
  88. Mobile Phone Detection of Atrial Fibrillation With Mechanocardiography
  89. Determinants of re-operation for bleeding in head and neck cancer surgery
  90. CHA2DS2-VASC AND HAS-BLED SCORES IN PREDICTING THE RISK OF STROKE VERSUS INTRACRANIAL BLEED: THE FIBSTROKE STUDY
  91. MOBILE PHONE DETECTION OF ATRIAL FIBRILLATION: THE MODE-AF STUDY
  92. PERFORMANCE OF CHA2DS2-VASC SCORE IN STROKE PREDICTION IN PATIENTS UNDERGOING SURGICAL AORTIC VALVE REPLACEMENT WITH BIOPROSTHESIS
  93. Value of DAPT score to predict adverse outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: A post-hoc analysis from the AFCAS registry
  94. Thromboembolisms related to post-operative electrical cardioversions for atrial fibrillation in patients with surgical aortic valve replacement
  95. Atrial Fibrillation Detection via Accelerometer and Gyroscope of a Smartphone
  96. Comprehensive Analysis of Cardiogenic Vibrations for Automated Detection of Atrial Fibrillation Using Smartphone Mechanocardiograms
  97. Occurrence and Classification of Cerebrovascular Events after Isolated Bioprosthetic Surgical Aortic Valve Replacement: A Competing Risk Analysis of the CAREAVR Study
  98. Outcome of octogenarians with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry
  99. Population trends in mitral valve surgery in Finland between 1997 and 2014: the finnish CVD register
  100. Clinical manifestations and outcomes of severe warfarin overanticoagulation: from the EWA study
  101. Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
  102. Transfusion and blood stream infections after coronary surgery
  103. Automated Detection of Atrial Fibrillation Based on Time–Frequency Analysis of Seismocardiograms
  104. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
  105. Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation
  106. Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry
  107. Imaging of αvβ3 integrin expression in experimental myocardial ischemia with [68Ga]NODAGA-RGD positron emission tomography
  108. Incidence and predictors of excessive warfarin anticoagulation in patients with atrial fibrillation—The EWA study
  109. Stroke recurrence in patients with atrial fibrillation: concomitant carotid artery stenosis doubles the risk
  110. Prediction of ineffective elective cardioversion of atrial fibrillation: a retrospective multi-center patient cohort study
  111. Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry
  112. Comparison of two different sampling intervals for optical coherence tomography evaluation of neointimal healing response after coronary stent implantation
  113. Mortality after stroke in patients with paroxysmal and chronic atrial fibrillation — The FibStroke study
  114. A smartphone-only solution for detecting indications of acute myocardial infarction
  115. Stroke as the First Manifestation of Atrial Fibrillation
  116. Atrial Fibrillation on Vitamin K Antagonist Oral Anticoagulant Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Acute Myocardial Infarction
  117. Trends in rates, patient selection and prognosis of coronary revascularisations in Finland between 1994 and 2013: the CVDR
  118. Permanent work disability in patients ≤50 years old after percutaneous coronary intervention and coronary artery bypass grafting (the CRAGS study)
  119. Detection of atrial fibrillation with seismocardiography
  120. Incidence and predictors of 30-day cardiovascular complications in patients undergoing head and neck cancer surgery
  121. Excessive intravenous fluid therapy in head and neck cancer surgery
  122. Postoperative Strokes and Intracranial Bleeds in Patients With Atrial Fibrillation: The FibStroke Study
  123. Early vascular healing after titanium–nitride–oxide-coated stent versus platinum–chromium everolimus-eluting stent implantation in patients with acute coronary syndrome
  124. Predicting the outcome of hip fracture patients by using N-terminal fragment of pro-B-type natriuretic peptide
  125. Strokes after cardioversion of atrial fibrillation — The FibStroke study
  126. Occurrence of postpericardiotomy syndrome admissions: A population-based registry study
  127. Automatic detection of atrial fibrillation using MEMS accelerometer
  128. Underuse of anticoagulation in stroke patients with atrial fibrillation - the FibStroke Study
  129. Outcome after coronary artery bypass grafting and percutaneous coronary intervention in patients with stage 3b–5 chronic kidney disease
  130. Predictors of permanent work disability among ≤50-year-old patients undergoing percutaneous coronary intervention
  131. Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial
  132. Ventricular rate during acute atrial fibrillation and outcome of electrical cardioversion: The FinCV Study
  133. Incidence and risk factors of postpericardiotomy syndrome requiring medical attention: The Finland postpericardiotomy syndrome study
  134. Bridging therapy with low molecular weight heparin in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: The AFCAS study
  135. Aberrant Circulating Levels of Purinergic Signaling Markers Are Associated With Several Key Aspects of Peripheral Atherosclerosis and ThrombosisNovelty and Significance
  136. Early Neointimal Coverage and Vasodilator Response Following Biodegradable Polymer Sirolimus-Eluting vs. Durable Polymer Zotarolimus-Eluting Stents in Patients With Acute Coronary Syndrome
  137. European Congress on e-Cardiology & e-Health October 2014, Selected Abstracts
  138. Prognosis and disease progression in patients under 50 years old undergoing PCI: The CRAGS (Coronary aRtery diseAse in younG adultS) study
  139. Comparison of 30-Day and 5-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients Aged ≤50 Years (the Coronary aRtery diseAse in younG adultS Study)
  140. Usefulness of Troponin T to Predict Short-Term and Long-Term Mortality in Patients After Hip Fracture
  141. Performance of Bleeding Risk-Prediction Scores in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
  142. Outcome after coronary artery bypass surgery and percutaneous coronary intervention in patients with atrial fibrillation and oral anticoagulation
  143. Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry
  144. Transthoracic echocardiography for non-invasive assessment of coronary vasodilator function after DES implantation
  145. Bivalirudin use during percutaneous coronary intervention in patients on chronic warfarin therapy
  146. CHADS 2 , CHA 2 DS 2 -VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention
  147. CLINICAL OUTCOME OF PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WITH BARE-METAL VERSUS DRUG-ELUTING STENTS: INSIGHTS FROM THE AFCAS REGISTRY
  148. IMPACT OF ANEMIA ON CLINICAL OUTCOME IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE AFCAS REGISTRY
  149. One-Year Outcome of Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting: An Analysis of the AFCAS Registry
  150. Bare-Metal vs. Drug-Eluting Stents in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
  151. Erratum to: Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial
  152. Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial
  153. Thrombocytopenia in Patients With Atrial Fibrillation on Oral Anticoagulation Undergoing Percutaneous Coronary Intervention
  154. Comparison of Additional Versus No Additional Heparin During Therapeutic Oral Anticoagulation in Patients Undergoing Percutaneous Coronary Intervention
  155. Pravastatin-induced improvement in coronary reactivity and circulating ATP and ADP levels in young adults with type 1 diabetes
  156. Impaired ATP-Induced Coronary Blood Flow and Diminished Aortic NTPDase Activity Precede Lesion Formation in Apolipoprotein E–Deficient Mice
  157. Cold Pressor Test Safety—The Incidence of Vasovagal Reactions
  158. Decreased endothelin-1 levels after acute consumption of red wine and de-alcoholized red wine
  159. Cardiopulmonary involvement in Fabry’s disease
  160. Cardiac magnetic resonance imaging in valvular heart disease
  161. Echocardiography in Fabry disease: diagnostic value of endocardial border binary appearance
  162. High dose of red wine elicits enhanced inhibition of fibrinolysis
  163. Effects of cognac on coronary flow reserve and plasma antioxidant status in healthy young men
  164. Assessment of coronary blood flow and the reactivity of the microcirculation non-invasively with transthoracic echocardiography
  165. A moderate dose of red wine, but not de-alcoholized red wine increases coronary flow reserve
  166. Vasodilation of Epicardial Coronary Artery can be Measured with Transthoracic Echocardiography
  167. Determinants of coronary flow velocity reserve in healthy young men
  168. Comparison of MRI and positron emission tomography for measuring myocardial perfusion reserve in healthy humans
  169. Coronary artery diameter can be assessed reliably with transthoracic echocardiography